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Stlmmary 
A locus involved in the biosynthesis of gonococcal lipooligosaccharide  (LOS) laas been cloned 
from gonococcal strain F62. The locus contains five open reading frames. The first and second 
reading frames are homologous, but not identical, to the fourth and fifth reading frames, respectively. 
Interposed is an additional reading frame which has distant homology to the Escherichia coli rfaI 
and r~J genes, both glucosyl transferases involved in lipopolysaccharide  core biosynthesis. The 
second and fifth reading frames show strong homology to the lex-1 or lic2A gene of Haernophilus 
influenzae, but do not contain the CAAT repeats found in this gene. Deletions of each of these 
five genes, of combinations of genes, and of the entire locus were constructed and introduced 
into parental gonococcal strain F62 by transformation. The LOS phenotypes were then analyzed 
by SDS-PAGE and reactivity with monoclonal antibodies.  Analysis of the gonococcal mutants 
indicates  that four of these genes are the glycosyl transferases that add GalNAc/31 ~  3Gal~l 
4GlcNAcB1 ~  3Gal/31 ~  4 to the substrate GlcB1 ~  4Hep ~  R  of the inner core region. 
The gene with homology to E. coli ~I/rfaJ is involved with the addition of the or-linked galactose 
residue in the biosynthesis of the alternative LOS structure Galotl -~ 4Gal/31 ~  4G1c~1 ~  4Hep 
R. Since these genes encode LOS glycosyl transferases they have been named IgtA, lgtB, IgtC, 
IgtD, and IgtE. The DNA sequence analysis revealed that lgtA, IgtC, and IgtD contained poly-G 
tracts, which, in strain F62 were, respectively, 17, 10, and 11 bp. Thus, three of the LOS biosynthetic 
enzymes are potentially susceptible  to premature termination by reading frame changes.  It is 
likely that these structural features are responsible  for the high-frequency genetic variation of 
gonococcal LOS. 
W 
'hile Neisseria species commonly  colonize many mam- 
malian hosts, human beings are the only species sub- 
ject to invasive disease by members of this species. Neisseria 
rneningitidis is the etiologic agent for septicemia and menin- 
gitis that may occur in epidemic form. Neisseria gonorrhoeae 
is the causative agent of gonorrhea and its manifold compli- 
cations. These organisms, particularly the gonococcus, have 
proved remarkably adept at varying the antigenic array of 
their surface-exposed molecules, notably their adhesive pili 
and opacity-related proteins. The genetic mechanisms for the 
variation of pilus (1-4) and opacity-related (5-7) protein ex- 
pression are in the main well understood. Like other gram- 
negative bacteria  the Neisseria species carry LPS in the ex- 
ternal leaflet of their outer membranes (8). In contrast to the 
high molecular weight LPS molecules with repeating O-chains 
seen in many enteric bacteria,  the LPS of Neisseria species 
is  of modest  size  and  therefore  is  often  referred  to  as 
lipooligosaccharide (LOS) 1. Although the molecular size of 
1 Abbreviations used in this  paper: CMP-NANA, N-acetyl neuraminic acid 
cytidine monophosphate; GC, gonococcus; LOS, lipooligosaccharide;  wt, 
wild-type. 
the LOS is similar  to that seen in rough LPS mutants of 
Salmonella species, this substance has considerable antigenic 
diversity. In the case of the meningococcus, a serological typing 
scheme has been developed that separates strains into 12 im- 
munotypes (9,  10). A remarkably complete understanding 
of the structure of meningococcal LPS (for review see refer- 
ence 11) has resulted from the studies ofJennings et al. (12), 
Michon et al. (13), Gamian et al. (14), and Pavliak et al. (15). 
In the case of N. gonorrhoeae, antigenic variability is so pro- 
nounced that a serological classification scheme has proved 
elusive. In part this is due to the heterogeneity of LOS syn- 
thesized by a particular strain; LOS preparations frequently 
contain several closely spaced bands by SDS-PAGE (16). Fur- 
thermore, studies using monoclonal antibodies indicate that 
gonococci are able to change the serological characteristics 
of the LOS they express, and that this antigenic variation 
occurs  at a frequency of 10-2-10 -3,  indicating that some 
genetic mechanism must exist to achieve these high frequency 
variations  (17, 18). Because of the molecular heterogeneity 
and antigenic variation of the LOS produced by gonococci, 
the determination of the structural chemistry of this antigen 
has proved to be a difficult problem, and definitive informa- 
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Volume 180  December 1994  2181-2190 tion based on very sophisticated analyses has only recently 
become available (19-22).  These are summarized in Fig.  1. 
Of particular interest is the presence of the tetrasaccharide 
Gal31 -+ 4GlcNAc/31 --~ 3Ga131 ~  4Glc31 --+ 4, which is 
a perfect mimic of lacto-N-neotetraose of the sphingolipid 
paragloboside (23, 24). In LOS, this tetrasaccharide frequently 
bears an additional N-acetylgalactosamine  residue (GalNAcfll 
--~ 3Ga131 ~  4GlcNAc31 --~ 3Gal31 --~ 4Glcfll ~  4), and 
then it mimics gangliosides. In some strains of gonococci, 
an alternative side chain is found that has the structure Galal 
"-~ 4Gal31 ~  4Glc31 --~ 4Hep ~  R  (21). This is a mimic 
of the saccharide portion of globoglycolipids (25), and is the 
structure characteristically found in N. meningitidis  immuno- 
type L1. 
The LOS molecules have a number of biological activities. 
They are potent endotoxic molecules believed to be the toxin 
responsible for adrenal cortical necrosis seen in severe menin- 
gococcal disease. They serve as the target antigen for much 
of the bactericidal activity present in normal or convalescent 
human sera (26). Gonococci possess a very unusual sialyl trans- 
ferase activity: they can use externally supplied N-acetyl neur- 
aminic acid cytidine monophosphate (CMP-NANA) and add 
NANA to the LOS on the surface of the organism (27-29). 
Group B and C meningococci have the capacity to synthe- 
size CMP-NANA, and frequently sialylate their LOS without 
requiring exogenous CMP-NANA (30).  In N. meningitidis 
strain 6275 immunotype L3, the sialic acid unit is linked ol2 
3 to the terminal Gal residue of the lacto-N-neotetraose 
Lacto-N-neotetraose 
I  I 
~~~RI 
1-1-M  3Fll & 9-2-L3,7,9  i  2-1-L8 & 4C4 
Monoclonal Antibodies 
17-1-LI 
112 
Figure  1.  Alternative structures found in gonococcal LOS.  R1 refers 
to the inner core region of LOS, consisting of two keto-deoxy-octulosonic 
acid residues. These in turn are attached to a lipid A structure. R2 in gono- 
cocci is typically GlcNAc31  -~ 2Hepofl  ~  3.  The structure in the top 
panel contains a tetrasaccharide identical to lacto-N-neotetraose found in 
paragloboside glycolipids. In many strains, this tetrasaccharide bears a ter- 
minal GalNAc31 ~  3. The lower panel shows an alternative trisaccharide 
structure with the terminal Gal ~1 --* 4 linked. This trisaccharide is seen 
in meningococci of the L1 serotype and in some gonococcal strains. The 
portions of the two structures recognized by the monoclonal antibodies 
used in this study are indicated: 4C4 (39), 3Fll (24, 69) 1-1-M (69), 2-1- 
L8 (21, 38, 72), 9-2-3,7,9, and 17-1-L1  (Zollinger, W. D., personal com- 
munication). 
chain (31). The levels of CMP-NANA found in various host 
environments is su~dent to support this reaction (32). The 
sialylation of LOS causes gonococci to become resistant to 
the antibody complement-dependent bactericidal effect of 
serum (28). The resistance is not only to the bactericidal effect 
mediated by antibodies to LOS, but to other surface antigens 
as well (33). van Putten (34) has demonstrated that exposure 
of gonococci to CMP-NANA markedly reduces their ability 
to invade epithelial cells  in tissue culture.  These findings 
strongly suggest that the ability of gonococci to vary the 
chemical nature of LOS provides them with the ability to 
cope with different host environments (35). 
Perhaps most telling, it has been found that LOS variation 
is selected in vivo in infections of human beings. A  well- 
characterized gonococcal laboratory strain MSllmk variant A 
was used to inoculate volunteers (36).  Over a period of 4-6 
d, the population of gonococci recovered in the urine of the 
two infected individuals increasingly shifted to two variants 
that expressed antigenically different LOS (37). A structural 
analysis revealed that the inoculated variant A produced a trun- 
cated LOS containing only the 3-1actosyl group linked to 
Hepl, while one of the new variants (variant C) produced 
a complete LOS (20). This suggests that the addition of the 
additional sugars GalNAcB1 -* 3Gal31 -~ 4GlcNAcB1 
3 is likely to be under control of a phase variation mechanism. 
Little information on the genetics of LOS synthesis in Neis- 
serm is available. A major advance has been the creation (38) 
and biochemical characterization (21) of five pyocin mutants 
of gonococcal strain 1291, dubbed 1291a-e.  Immunological 
and biochemical data have shown that 1291a, 1291c, 1291d, 
and I291e produce LOS with sequential shortening of the 
lacto-N-neo.tetraose chain, with mutant  1291e lacking the 
glucose substitution on the heptose. Mutant 1291b synthe- 
sizes the alternative LOS structure Galcr  -~ 4Gal31 ~  4Glc 
(Fig.  1). Only the genetic basis of the 1291e mutant is now 
defined. It is a mutation of phosphoglucomutase (pgra), wlfich 
precludes the synthesis of UDP-glucose and hence the addi- 
tion of the first residue of the lacto-N-neotetraose unit (39, 
40).  It also  has been shown that galE mutants of menin- 
gococcus or gonococcus produce truncated LOS in keeping 
with the inability to synthesize UDP-galactose (41,  42). 
We describe a locus in N. gonorrhoeae  strain F62 containing 
five genes. Four of the genes are responsible for the sequen- 
tial addition of the GalNAr~l -* 3GalB1 --~ 4GlcNAc31 -* 
3Gal31  "-*" 4 to the substrate GlcB1  -~ 4Hep ~  R  of the 
inner core region (19). The fifth gene is involved with the addi- 
tion  of the a-linked galactose residue in the biosynthesis 
of the alternative LOS structure Galod -* 4GalBl --~ 4Glc31 
--~ 4Hep -~ R  (21).  DNA sequence analysis revealed  that 
the first, third, and fourth reading frames contained poly-G 
tracts, which in strain F62 were, respectively, 17,  10,  and 
11 bp. Thus, three of the LOS biosynthetic enzymes are poten- 
tially susceptible to premature termination by reading frame 
changes, as has been reported for the gonococcal piIC genes 
(43, 44). It is likely that these structural features are respon- 
sible for the high-frequency genetic variation of gonococcal 
LOs  08). 
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Reagents and Chemicals.  Most laboratory chemicals  were ob- 
tained from Sigma Chemical Co. (St. Louis, MO). Restriction en- 
zymes were purchased from New England Biolabs (Beverly, MA). 
Media and Growth Conditions.  Escherichia  coli  strains were grown 
in solid or liquid Luria-Bertani (LB) medium (45); antibiotics were 
added as applicable. Carbenicillln was used at 50/zg/ml and eryth- 
romycin at 200/~g/ml. N. gonorrhoeae strain F62 was grown on 
gonococcus (GC) agar (46) or GC agar containing 2/zg/ml eryth- 
romycin. For isolation of LOS or genomic DNA, gonococci were 
grown in 1.5% proteose peptone broth (Difco Laboratories, Detroit, 
MI), 30 mM phosphate, 8.5 mM NaC1 supplemented with 1% 
isovitalex (Becton Dickinson Microbiology Systems, Cockeysville, 
MD). 
Recombinant DNA Methods.  Plasmids  were purified using ei- 
ther Qiagen columns or the QIAprep spin columns obtained from 
Qiagen,  Inc. (Chatsworth,  CA). Digestion with restriction en- 
zymes, gel electrophoresis,  ligations with T4 DNA polymerase, 
and transformation of E. coli were done according to the method 
of Sambrook et al.  (45).  Southern hybridization was performed 
on membranes (Hybond N +; Amersham Corp., Arlington Heights, 
IL) with  DNA  labeled  with  an  ECL  kit  (Amersham  Corp.). 
Genomic DNA was isolated as described by Moxon et al. (47). 
A gene bank of N. gonorrhoeae strain F62 genomic DNA was 
constructed by ligating '~20-kb fragments obtained by incomplete 
digestion with Sau3A into BamHI/EcoRJ-digested X2001 (48). 
The phage library was screened by hybridization with random 
prime-labeled plasmid pR10PI,  and five clones  were isolated  by 
plaque purification. The phages from these clones  were purified 
by sedimentation followed by flotation on CsC1 (49), and the DNA 
was isolated. From one of these clones, two ClaI fragments of 4.9 
and 3.4 kb were isolated by gel electrophoresis and recovery with 
Geneclean II (BIO 101, Inc., La Jolla, CA).  These were ligated 
into ClaI-cut pBluescript II SK- (Stratagene,  Inc., La Jolla, CA) 
and called p4900 and p3400, respectively, p4900 contained a PstI 
site in the insert and was subdivided  into two clones containing 
inserts of 2.1 and 2.8 kb. The clone containing the 2.8-kb insert 
was called pPstCh. The inserts in p3400 and pPstCla were sequenced 
by the chain termination method (50) using Sequenase II (United 
States  Biochemical Corp.,  Cleveland,  OH),  All of the sequence 
presented in Fig. 2 was completed in both directions;  part of the 
sequence  was  determined  by LARK  Sequencing  Technologies 
(Houston, TX). 
The insertion and deletions shown in Fig. 6 were constructed 
as follows.  I1, I3, A1  and A2 used plasmid pPstCla cut, respec- 
tively, with BsaBI, AscI, and StyI and double cut with StyI and 
BsaBI. I2 and A3 used plasmid p3400 cut with AgeI or StyI. The 
complete locus was assembled by cloning the ClaI-ApaI fragment 
from p3400 into pPstCla cut with ClaI and ApaI, and the plasmid 
was called pLOS5. Deletions A4 and A5 were constructed by use 
of pLOS5 and digestion with StyI and BbsI or StyI alone.  In all 
instances  (except digestion with BsaBI),  the cut plasmids  were 
treated with the Khnow fragment of E. cold DNA polymerase to 
blunt the ends,  and ermC' (erythromycin resistance  marker) was 
inserted. The ermC' gene was isolated  from plasmid plM13 (51) 
as a ClaI-HindlII fragment and cloned into the same sites in plasmid 
pHSS6 (52). From this plasmid it was excised as a NotI fragment, 
the ends blunted by treatment with Klenow fragment of DNA 
polymerase and purified by gel electrophoresis and recovery with 
Geneclean II (BIO 101 Inc.). 
Transformation of piliated N. gonorrhoeae strain F62 was per- 
formed with plasmids  isolated from E. coli (53) and the transfor- 
pPstCla 
I  I 
Sty I  BsaBI 
PstI  i~I  [ IBfaI  Ascii  ClaI 
I  I  I]o  I 
t  '  ]7  I  t 
poly-G  poly-G  poly-G 
#400 
I 
,StyI  BfaI 
i  istyI(4g  eI  !  ~  ApaI 
t  I  IS 
im  I  !  I  I  I 
glyS  lgtA  lgtB  18tC  lgtD  lgtE 
1000  2000  3000  4000  5000 
I  ~  I  ~  I  ~  I  ~  I  ~  I 
Figure 2.  Genetic map of the LOS locus based on the DNA sequence. 
Sequence information for bp 1-2,725 was obtained from plasmid pPstCla 
and bp 2,725-5,859 from plasmid p3400 (see Materials and Methods). IS 
refers to an area of the sequence  that has homology to a previously  reported 
neisserial insertion  sequence  ISl106 (64). The positions  of the reading  frames 
of IgtA-E are indicated. Three tracts of poly-G were found in IgtA (17 
bp), lgtC (10 bp), and IgtD (11 bp) and are indicated by vertical black bars. 
mants selected on GC agar (46) containing 2 #g/ml erythromycin. 
The fidelity of the genomic alteration of each of the gonococcal 
transformants was verified by sequencing the upstream and down- 
stream junctions of the ermC' gene in their genomic DNA by use 
of a PCR technique.  Two 5' biotinylated primers (GCCGAGAAA- 
ACTATIGGTGGA and AAAACAWA2AGGAATTGACGAT) were 
synthesized; these were based on the ermC' sequence near its up- 
stream and downstream ends, respectively. The primers were de- 
signed  such  that their 3' ends pointed outward from the ermC' 
gene. Each of these primers was used together with a suitable primer 
matching the sequence of the LOS locus near the putative inser- 
tion. PCR was performed according to the instructions supplied 
with the GeneAmp PCR Reagent Kit from Perkin Elmer (Branch- 
burg, NJ) using 25 cycles. In all instances the expected size product 
was obtained. The DNA sequence  of these products was deter- 
mined by purifying the PCR product on magnetic streptavidin beads 
from DYNAL, Inc. (Lake Success, NY) and sequencing with the 
Sequenase II kit according to a protocol provided by DYNAL, Inc., 
based on the method developed by Hultman et al. (54). The se- 
quences were analyzed by computer programs in the GCG package 
of Genetics Computer Group Inc. (Madison, WI). 
Immunological Methods.  Monoclonal antibodies  17-1-L1 (L1), 
9-2-L3,7,9 (L3), 2-1-L8 (LS) were provided as filtered ascites fluids 
by Dr. Wendell Zollinger (Walter Reed Army Institute for Re- 
search, Washington DC). Dr. Michael ApiceUa (University of Iowa, 
Iowa City, IA) supplied  antibody 1-1-M as ascites fluid and 3Fll 
and 4C4 as tissue  culture supernatants. LOS was extracted from 
each of the gonococcal mutants by the hot phenol-water method 
(55) and purified as described (56). The LOS was diluted to 200 
/~g/ml in the Western blot buffer described by Towbin et al. (57), 
and 1.5 #1 aliquots were spotted on Immobilon-P membrane from 
Millipore Corp. (Bedford, MA) that was lying on 3MM filter paper 
(Whatman Ltd., Maidstone, UK) soaked in the blotting buffer. 
The spots were allowed to absorb into the membrane over a period 
of 2 rain, and the strips were placed in blocking buffer for at least 
60 min. The blocking buffer consisted of 3% gelatin dissolved in 
150 mM NaC1,  10 mM Tris-HC1,  pH 7.5,  5 mM MgC12, and 
0.02%  NAN3. The strips  were washed  three times in the same 
buffer containing 1% gelatin. The strips were treated for 2 h with 
monoclonal antibodies diluted in blocking buffer. The antibodies 
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able as tissue culture supernatants were diluted 1:10. The strips 
were washed, incubated for 60 rain with a 1:1,000 dilution  of 
phosphatase-conjugated  anti-IgG, IgA, IgM (Organon Teknika  Co., 
Durham, NC), washed, and stained as described previously (58). 
GelElectrophoresis. Gel electrophoresis  of  LOS samples  was per- 
formed as described by Lesse et al. (59), and the gels were silver 
stained (60). 
Results 
Cloning of the LOS Locus.  During attempts to isolate the 
porin gene of N. gonorrhoeae, pBR322  clones containing a 
4.9-kb ClaI fragment were repeatedly isolated that reacted 
by colony blots with a rabbit antiserum to purified porin. 
An immunoreactive subclone, pR10PI, consisting of a 1,305- 
bp R.saI-ClaI fragment, was derived and its DNA sequence 
determined. This sequence had homology to a gene isolated 
from Haemophilus influenzae, called lex-I (61) or lic2A (62), 
that is known to be involved in LPS synthesis of that species. 
Using subclone pR10PI as a probe, Southern blots ofN. gonor- 
rhoeae genomic DNA digested with ClaI revealed hybridiza- 
tion with two fragments, 4.9 and 3.4 kb, respectively. How- 
ever, digestion with some other restriction enzymes gave rise 
to only a single band. Notably, digestion with BfaI gave rise 
to a single band of 4.1 kb, suggesting that the two copies 
were closely linked (data not shown). 
A  )~2001 bank of N. gonorrhoeae strain F62 DNA was 
screened by hybridization with pR10PI, and five clones were 
isolated. One of these clones, when digested with either ClaI 
or Bfal and examined by Southern hybridization with pR10PI 
used as the probe, gave rise to a pattern identical to that seen 
with genomic DNA. The appropriate ClaI fragments of this 
>,2001 clone were isolated and cloned into the ClaI site of 
pBluescript II SK-. The entire sequence of the 3,400-bp ClaI 
fragment was determined. Mapping of the done containing 
the 4,9(lO-bp ClaI fragment indicated that there was a single 
PatI site in the clone ,,,2.8 kb from one side, allowing the 
done to be divided into two subdones. Partial sequence of 
the ends of the 2.1-kb subclone indicated that it contained 
a coding frame homologous tothe E. coli COOH-terminal 
portion of the ot subunit of glycyl-tRNA synthetase (glyS) 
and the majority of the ~  subunit of this gene (63)￿9 The 
predicted length of DNA needed to match the E. coli  sequence 
was present; this clone was not examined further. 
DNA Sequence of the LOS Locus.  A summary of the fea- 
tures found by sequencing the two clones is illustrated in 
Fig.  2. The sequence has been deposited in GenBank with 
the acquisition number U14554. After theglyS gene, we found 
five dosely spaced open reading frames. The last frame has 
46 bp downstream of the termination codQn a sequence typ- 
ical of a p-independent termination signal. Subsequently, there 
is an area of '~100-bp  that  has  striking homology to the 
ISl106  neisserial  insertion sequence (64).  Work presented 
below shows that the five open reading frames code for LOS 
glycosyl  transferases,  and  hence  they  have  been  named 
Igta-lgtE. 
Searches for internal homology within this locus indicates 
that the DNA coding for the first two genes (IgtA,  IgtB) 
is repeated as the fourth and fifth genes (IgtD, lgtE), and that 
interposed is an additional open reading frame, IgtC. This 
is in keeping with the data obtained by Southern hybridiza- 
tion presented above, in which pR10PI probe containing the 
lgtB and a small portion of the lgtC gene hybridized with 
two ClaI fragments, but with only one BfaI fragment (see 
positions of the BfaI  sites in the LOS locus in Fig.  2).  In 
more detail, 16 bp after the stop codon of the tRNA synthe- 
tase (glyS) is the beginning of a stem loop structure followed 
closely by a consensus ribosome binding site, and within 6 
bp is a TTG believed to be the initiation codon of IgtA. 2,871 
bp downstream from the beginning of the stem loop (closely 
following the stop codon of IgtC) there is an almost perfect 
repeat of the stem loop structure, the ribosome binding site, 
and the TTG initiation codon of IgtD with the downstream 
sequence strongly homologous for ",~500 bp. The sequences 
then diverge to some extent. However, at the beginning of 
IgtB and lgtE,  the homology again becomes nearly perfect 
for ,,o200 bases,  then diverges toward the latter part of the 
orfs. The similarity of the homologous proteins is illustrated 
in Figs. 3 and 4. It demonstrates the near-perfect conserva- 
tion of the primary structure in the NH2-terminal portions 
of the  molecules with  increasing  divergence toward  the 
COOH  termini of the proteins. 
The IgtC sequence interposed between the repeated por- 
tions of the locus is not repeated within the locus or in the 
N. gonorrhoeae genome (data not shown). It appears  to be 
homologous to E. coli rfaI or r~J genes, very closdy related 
genes that serve as glucosyl transferases  in core LPS biosyn- 
thesis (65).  The similarity of r~I with IgtC is illustrated in 
Fig.  5. 
We found that three of these genes contained within their 
igtA  i LQPLVSVLICAYNVEKYFAQSLAAVVNQTWRNLDILIVDDGSTDGTLAIA  50 
J  lltilt111J  tlllili*ti,i  tlllllthlr~11ttill~  I~l 
Itl~llJll~tll'llllllllllll'Jtllll  ii~,~i  ill  i; 
igtD  1 LQPLVSVLICAYNA~KYFAQSLAAWGQTWRNLD~LIVDDGSTDGTPAIA  50 
igtA  51 KDFQKRDSRIKILAQAQNSGLIPSLNIGLDELAKSGGGGGEYIARTDADD  100 
: ....  II  I:I .......  ,  .....  ,.,':IIIIIII~IIII  I111111111~ 
igtD  51 RHFQEQDGRrRIISNPRNLGFIASLNIGLDELAKS..GGGEYIARTDADD  98 
igtA  101  IASPGWIEKIVGEMEKDRSIIAMGAWLEVLSEEKDGNRLARHHKHGKIWK  150 
ii~*lttll,l~l  i  ￿9  * 
igtD  99  IASPGWIEKIVGEMEKDRSIIAMGAWLEVLSEENNKSVLAAIARNGAIWD  148 
igtA  151 KPTRHEDIAAFFPFGNPIHNNTMIMRRSVIDGGLRYDTERDWAEDYQFWY  200 
IIII~III  I  IIII  '''''~  ....  "IIII~III:I  ....... 
￿9  *  111111111111  -.  tlll.lll 
igtD  149  KPTRHEDIVAVFPFGNPIHNNTMIMRRSVIDGGLRFDPAYIHAEDYKFWY  198 
igtA 201 DVSKLGRLAyYpEALVKYRLHANQVSSKHSVRQHEIAQGIQKTARNDFLQ  250 
:  :IIIIIIIIIII""'  '  "'  'II￿9149  ........  :  I  I  I.:::.  ￿9  tl  .... 
IgtD  199 EAGKLGRLAyYPEALVKYRFHQDQTSSKYNLQQRRTAWKIKEEIRAGYWK  248 
igtA 251  SMGFKTRFDSLEYRQTKAAAYELPEKDLPEEDFERARRFLYQCFKRTDTP  300 
I:  I:I:I  '  "  '  ".I  "" 
igtO 249 AAGIAVGADCLNYGLLKSTAYALYEKALSGQDIGCLRLFLYEYFLSLEKY  298 
igtA 301  PSGAWLDFAADGRMRRLFTLRQYFGILYRLIKNRR  335 
￿9  ..:III  .I  I'"',.,,..,,"  ,,"  ::::  :: 
igtD  299  SLTDLLDFLTDRVMRKLF~J~PQYRKILKKMLRPWK  333 
Figure 3.  Homology  of the protein products of ~tA and ~tD. The 
primary structure  of two proteins is very  similar, particularly  in the first 
half of the sequences.  The glycine  residues starting at position 86 reflect 
the coding  of the poly-G  regions in the respective  genes. The Bestfit pro- 
gram of the Genetics  Computer  Group  package  was used, and the symbols 
,  :, and. represent  degrees  of similarity  based on the Dayhoff  PAM-250 
matrix. 
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LAEDTWLEERFDKDSAFIVRLETMFAKVIVRPDKVLNYENRSFPLLESEH 150 
CGTAGYIISRKAMRFFLDRFAVLPPERLHPVDLMMFGNPDDREGMPVCQL  200 
lUlaaalaal  alUlllllllllllll..llllll  a.  .  , 
llllllllll'llllllllllllllll,,.llllll,  l-lllll,l  ￿9 
CGTAGYIISREAMRFFLDRFAVLPPERIKAVDLMMFTYFFDKEGMpVYQV  200 
igtE 247 
NPALCAQELHYAKFHDQNSALGSLIEHDRRLNRKQQRRDSPANTFKHRLI 250 
llll  IIIIIIII  III  IIr  .I  I  I  l  I 
￿9  1111.11111111  .ill  ill  -i,i  1.1,11  .......  i 
SPALCTQELHYAKFLSQNSMLGSDLEKD  ....  REQGRRHRRSLKVMFDLK 246 
RALTKIGREREKRRKRR  .....  EQTIGKIIVPFQ 279 
III.I:(II:.II..I.  I...I:  ::  I. 
RALGKFGREKKKRMERQRQAELEKVyGRRVILFK 280 
Figure 4.  Homology of the protein products oflgtB and lgtE. The pri- 
mary structure of two proteins is very similar, particularly in the first half 
of the sequences. These sequences  also have significant homology to lex-1 
(62) and lic2A (62) genes of H. influenzae. For meaning of symbols, see 
Fig. 3. 
Figure 6.  Deletions in the LOS locus. Three insertions and five dele- 
tions of  the LOS locus  were  constructed  as detailed  in Materials  and Methods. 
The restriction  sites that were used are indicated. The insertions  are marked 
by triangles and the extent of the deletions by stippled boxes. The open 
arrows indicate the open reading frames disrupted by the construction. 
In each of the constructs, the erythromycin marker ermC' was inserted 
at the site of the insertion or the deletion. 
coding frame runs of guanosines coding for stretches of gly- 
cines (Fig. 2). These poly-G regions were found in IgtA (17 
bp), lgtC (10 bp), and IgtD (11 bp); in each case, the number 
of G residues was one that maintained an intact reading frame 
(Figs.  3  and  5).  In each of the three genes,  a  change of 1 
or 2 G bases would cause premature termination of the tran- 
script. 
LOS PhenotylJe of Neisseria gonorrhoea F62 with Deletions 
of the LOS Locus.  To define the function of the Igt genes, 
insertions  or deletions of the LOS locus  were constructed 
in plasmids propagated in E. coil The insertions or deletions 
in each case were marked with the ermC' gene, which is an 
excellent selective marker in N. gonorrhoeae (53).  The con- 
structions  are summarized in Fig.  6.  I1, I2,  and I3 refer to 
insertions  of the ermC'  marker into,  respectively, a BsaBI, 
rfaI  29 LDIAYGTDKNFLFGCGISIASILKYNEGSRLCFHIFTDYFGDDDRKYFDA  78 
.11  ,.  i  J,  ￿9  ,  ..... ,-,-  .:.  I:  :-:-  = II::..  ::=:=I  ..I 
IgtC  I MDIVFAADDNYAAYLCVAAKSVEAAHPDTEIRFHVLDAGISEENRAAVAA  50 
rfaI  79 LALQYKTRIKIYLINGDRLRSLP.STKNWTHAIYFRFVIADYFINKAPKV  127 
￿9  I.  ""  :I-:  ::I  :  :::  ......  :  ..::...I  I  I  I .... II 
IgtC  51  .NLRGGGNIRFIDVNPEDFAGFPLNIRHISITTYARLKLGEY.IADCDKV  98 
rfaI  128 LYLDADIICQGTIEPLINFSFPDDKVAMVV...TEGQADWWEKRAHSLGV  174 
''"  ""  'I  =  .:.:=  I:  :  ~  I.::.:I  :I:  iiii.i  ........  i  ￿9  ,  . 
igtC  99 LYLDTDVLVRDGLKPLWDTDLGGNWVGACIDLFVERQEGYKQK  ....  IGM 144 
rfaI  175 AGIAKGYFNSGFLLINTAQWAAQQVSARAIAMLNEPEIIKKITHPDQDVL  224 
.......  =::  ....  :::  ￿9  :  ....  III:I 
igtC 145 AD.GEYYFNAGVLLINLKKWRRHDIFKMSCEWVEQYKDVMQ..yQDQDIL 191 
rfaI 225 NMLLADKLIFADIKYNTQFSLNYQLKESFINPVTNDTIFI  .......... 264 
I  I:  :  :.:I:  ""  ￿9 .,  =.  II.:...  :..  .I.::: 
IgtC  192 NGLFKGGVCYANSRFNF.MPTNYAFMANGFASRHTDPLYLDRTNTAMPVA  240 
rfaI 265  ..HYIGPTKPWHDWAWDYPVSQAFMEAKNASPWKNTALLKPNNSNQLRYS  312 
II.l..llll  :I:.I..I  ￿9  ..  I:.:  I-:  ...:. 
igtC 241 VSHYCGSAKPWH...RDCTVWGAERFTELAGSL..TTVPEEWRGKLAVPp  285 
rfaI 313 AKHMLKKHRYLKGFSNYLFYFI 334 
￿9 I  II  :I:  I  :I-  ==  I 
igte 286  TKCML..QRWRKKLSARFLRKI  305 
Figure  5.  Homology of the protdn products of r~I and ~tC. The E. 
coli ~'aI  and ~JaJ  genes are very closely  related. They serve  as glucosyl  trans- 
~rases of two glucose residues in the LPS core region (65). The glydnes 
at position 54-56 in ~tC are encoded by the poly-G tract. For meaning 
of symbols, see Fig. 3. 
AgeI, and AscI site. Similarly, the deletions were constructed 
by excising portions of the plasmids and substituting the eryth- 
romycin marker. The open arrows indicate the gene or genes 
disrupted.  Each of these plasmids was used to transform N. 
gonorrhoeae strain  F62,  and transformants  were selected on 
erythromycin-containing plates. The fidelity of the genomic 
alteration of a prototype of each of the gonococcal transfor- 
mants was verified by sequencing the upstream  and down- 
stream junctions of the ermC' gene. To simplify the nomen- 
clature, in this report the gonococcal mutants have been given 
the same names used to identify the plasmid constructs shown 
in Fig.  6. 
The LOS of the mutants  were examined by SDS-PAGE 
and compared with the LOS of strain 1291e.  This strain was 
originally isolated by Dudas  and Apicella (38)  as a pyocin- 
resistant mutant of strain 1291 wild-type (wt) and has been 
extensively characterized,  both  chemically and  genetically. 
Chemical analysis has shown that this mutant lacks completely 
the lacto-N-neotetraose substitution on heptose 1 (21). The 
genetic basis of this mutant has been defined (39, 40); it is 
a mutation  of the pgm  gene coding for phosphoglucomu- 
tase. This mutation prohibits the synthesis of UDP-glucose 
and hence the addition  of glucose to the heptose.  As  seen 
in Fig. 7, the parental wt F62 strain gives rise to two major 
LOS bands;  their appearance is indistinguishable from SDS- 
PAGE patterns previously published by other workers (66). 
The mutants  are arranged on the gel according to the size 
of the major band that they contain. The size decreases from 
the top band of the F62 wt LOS in four clear steps to the 
size of the LOS of A4 or I2. Since the I2 mutant  (with an 
insertion into IgtE,  the last gene in the locus) has the same 
phenotype as A4 (which has a complete deletion of the locus), 
it suggests  that the lgtE product performs the first biosyn- 
thetic step. Thus, the enzymes encoded by IgtA-D, although 
intact,  do not have a  substrate  to act upon.  Mutant  A5  (a 
deletion of the locus with the exception of IgtE)  gives rise 
2185  Gotschlich Figure  8.  Reactivity  of LOS 
from strain F62 wt and mutants 
with monoclonal  antibodies.  The 
names of the following mono- 
clonal antibodies were abbrevi- 
ated: 17-1-L1  (LI), 9-2-L378 (L3), 
2-1-L8 (L8). Purified  LOS was ap- 
plied to Immobilon-P  membranes, 
allowed to react with the anti- 
bodies, and developed  as described 
in Materials and Methods. The 
specificity  of the monoclonal  an- 
tibodies is summarized  in Fig. 1. 
Figure 7.  Silver-stained  SDS-PAGE  of  LOS preparations. Gel dectropho- 
resis of purified  LOS samples of 375 ng was performed  and stained  as de- 
scribed in Materials  and Methods. Above the gel are indicated  the struc- 
ture of the LOS of" the major  bands inferred  to be present in each of the 
preparations. These structures  are based  on the reactivity  with monoclonal 
antibodies shown in Fig. 8, but are presented in this figure  to facilitate 
interpretation  of the patterns observed. R stands  for the inner  core  region 
and lipid A. 1291e  is a pyocin-resistant  mutant (38). 
to a LOS that is one step  larger,  supporting the idea that 
this gene accounts for the initial biosynthetic step. Note that 
the LOS of  both I2 and A4 mutants is perceptibly larger than 
the LOS of strain 1291e, which is known to be unable to 
add glucose, the first residue in the lacto-N-neotetraose chain. 
These data suggest that IgtE encodes  the galactosyl trans- 
ferase enzyme, which adds the first galactose of the lacto-N- 
neotetraose chain. 
The LOS preparations were also studied by use of a dot 
blot technique for their reactivity with monoclonal antibodies. 
The monoclonal antibodies used and their reported specificities 
are shown in Fig. 1. The reactions observed  with the LOS 
obtained from the parental strain and the mutants are sum- 
marized in Fig.  8. The reactivity of the parental F62 with 
1-1-M, 3Fll, and L8 was as reported previously by Mandrell 
et al. (67) and Yamasaki et al. (68). Mutants A4 and I2 fail 
to react with any of the antibodies. However, A5 gives a strong 
reaction with antibodies 4C4 and LS, indicating that the first 
galactose residue is present. This is in keeping with the SDS- 
PAGE results (see Fig.  6)  and supports the role of lgtE as 
the galactosyl transferase. It also indicates that deletions up- 
stream of lgtE do not significantly inactivate its function by 
polar effect  s. The LOS of F62 wt parent has strong reactivity 
with L3 and weak reactivity with 3Fll.  It is known that 
reactivity 3Fll is occluded by the addition of the GalNAc 
residue (37); this is not the case with the L3 antibody. The 
wt LOS reacts with 1-1-M,  the antibody reactive when the 
terminal GalNAc residue is present. The reactivity with 1-1- 
M is lost in A3, which has a deletion only in IgtD. This sug- 
gests that this gene encodes the GalNAc transferase. The re- 
activity with antibody L1 (specific for the alternative LOS 
structure capped with an al --* 4Gal) is not seen in wt LOS, 
is absent in I1, and all deletions that affect IgtC.  The reac- 
tivity is strongest in A1, which has a deletion of IgtA only. 
Note that this mutant also has lost reactivity with 3Fll and 
L3. These two findings suggest that IgtA codes for the GlcNAc 
transferase,  and when this residue is not added, the incom- 
plete chain is a substrate for the action of IgtC to produce 
the alternative LOS structure. The sizes of the LOS products 
seen in Fig. 7 are in accord.  This suggests that lgtC encodes 
the ot-Gal transferase. This is further supported by the weak 
reactivity of mutant A3 with antibody L1. Mutant A3 has 
a deletion of lgtD and fails to add the terminal GalNAc, al- 
lowing the ot-Gal transferase to modify  the lacto-N-neotetraose 
group to produce a Pi-like globoside (25). Mutant I3 (with 
inactive lgtB) has lost reactivity with 1-1-M,  3Fll, and L1, 
and remains only weakly reactive with L3. Together with 
the size of the product, these observations suggest that lgtB 
encodes the galactosyl transferase-adding Gal~l ~  4 to the 
GlcNAc residue. Ricinus lectin RCA-I is specific for terminal 
galactose in B linkage (69,  70) and was used to confirm the 
presence  of this structure on the LOS preparations.  Using 
ELISA tests,  we found that wt, A3, A2, and A5 LOS,  ex- 
pected to bear a terminal/3Gal, bound the lectin (Fig.  7), 
while A4, I2, A1, and I3 were unreactive (data not shown). 
Discussion 
We have cloned a locus containing five open reading frames. 
The effect of eight defined mutations within this locus on 
the size and serological  reactivity of the LOS produced by 
gonococcal transformants suggests that these genes are the 
glycosyl transferases responsible for the biosynthesis of most 
of the lacto-N-neotetraose chain. The data obtained allow 
a tentative identification of the function of each of these genes. 
It is noteworthy that IgtB and IgtE, which are structurally 
very closely related, also perform an apparently very similar 
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tively, GlcNAc or Glc). Similarly, the very related IgtA and 
IgtD add, respectively, GalNAc or GlcNAc B1 -~ 3 to a Gal 
residue,  lgtC, which is unrelated to the other genes in the 
locus, is responsible for the addition of a Galcd -~ 4. A full 
structural analysis of the LOS products of each of the mu- 
tants is in progress. 
The DNA sequence showed that three of the genes (IgtA, 
IgtC, and IgtD) contain tracts of guanosines, which code for 
glycines residues in the proteins. These provide a potential 
mechanism for high-frequency  variation of expression of these 
genes. Slippage in such poly-G tracts is well documented to 
control the expression of the gonococcal pilC genes, with 
resultant effects on pilus adhesiveness to human epithelial cells 
(44). In strain F62, the numbers of bases in each of the three 
poly-G regions were such that the proteins are in frame; this 
is in keeping with the ability of F62 wt to produce a com- 
plete LOS,  including the addition of the terminal GalNAc. 
Three aspects of LOS biosynthesis would potentially be sub- 
ject to high-frequency variation. The first is the addition of 
the terminal GalNAc (lgtD). This would cause an alteration 
of reactivity with monoclonal antibody 1-1-M, and this phase 
variation has been reported by van Putten (34).  Similarly,  a 
change in lgtA  would cause the failure of the addition of 
GlcNAc to the growing chain and truncate the LOS at the 
13-1actosyl level. This is a very common form of LOS in gono- 
cocci, with a 3.6-kD molecule that confers resistance to the 
bactericidal effect of normal human serum (71). It is tempting 
to speculate that the in vitro variation between variants A 
and C  of MSllmk from the fl-lactosyl chain to a complete 
LOS (which had a selective advantage in vivo in the volunteers) 
could be explained by regaining functional expression of the 
GlcNAc transferase IgtA. Finally, the variable addition of o~1 
-~ 4Gal to either the 13-1actosyl (pk-like globo-triose) or the 
lacto-N-neotetraose group (Pi-like globoside) (25) would be 
under the control of the expression of IgtC. The activity of 
the IgtC transferase appears to compete poorly with the other 
transferases  for precursor, and its activity is evident only if 
either IgtA  or IgtD is silent. For the Galotl -~ 4GalB1  -~ 
4Glc trisaccharide to be synthesized, the GlcNAc transferase 
lgtA  must  be  inactive,  and  for  expression  of the  Pi-like 
globoside Galoll -~ 4GalB1  -~ 4GlcNAcB1 -~ 3Gall31 -* 
4Glc,  the GalNAc transferase IgtD must be silent. 
Comparable  high-frequency  antigenic  variation  of H. 
influenzae LOS has also been noted and has been attributed 
to changes in translational frame caused by shifts in the number 
of CAAT repeats in two separate loci, licl (72) and lic2 (62). 
Shifts allowing the expression of the lic2 gene are correlated 
with the expression of an epitope with the structure Galcd 
-* 4Ga1131 --~ . Since the lic2 gene is homologous to IgtB 
and lgtE, the galactosyl transferases  that link Gall31 ~  4 to 
Glc or GlcNAc, respectively, it is likely that this is its func- 
tion in H. influenzae LOS synthesis. It is remarkable that, 
while both these mucosal pathogens have evolved frame shift 
mechanisms to  cause antigenic variation of the LOS,  the 
gonococcal homologs of lic2 (IgtB and IgtE) are not the ones 
that contain poly-G tracts. 
While the ftame-shift mechanisms discussed above are suited 
for on/off regulation of gene expression, the structure of the 
locus also lends itself to more subtle regulation of the level 
of expression of the genes.  It has been demonstrated that 
growth rate affects the molecular weight distribution and an- 
tigenic character LOS species produced (73). While we have 
not determined the size of the KNA transcripts, it is very 
likely that IgtA, IgtB, and lgtC (in the instance where the 
poly-G tracts are such that the coding frame is maintained) 
are transcribed together. The termination codon of IgtA and 
the initiation codon of lgtB in fact overlap,  and the distance 
between the TAA of IgtB and the ATG of IgtC is only 11 
bp. Similarly, the stop codon of lgtD and the start codon of 
lgtE are separated by only 18 bp. Yet the organization is such 
that if any of the three genes subject to phase variation are 
in the off configuration, then transcription is able to reinitiate 
effectively at the beginning of the next gene. This ability 
to reinitiate transcription was clearly seen with the muta- 
tions constructed in this  study. 
The correlation of LOS structure with function is still in 
its early stages.  The major advances  in the field have been 
the development of an understanding of the structure of the 
molecules and the ability to relate this, often unambiguously, 
to the reactivity with a number of weU-characterized mono- 
clonal antibodies. Added to this is the realization that, in the 
in vi~r  environment, which provides CMP-NANA, the or- 
ganisms may or may not sialylate  the LOS, depending on 
whether the LOS synthesized is a competent acceptor struc- 
ture. It is well known that sialylation induces a serum-resistant 
state in many strains.  However, the effect of sialylation in 
local infection is not as well studied, van Putten (34) has shown 
that sialylation of LOS has a marked inhibitory effect on epi- 
thelial cell invasion, without apparently greatly altering adhe- 
sion. His studies suggest that, in the mucosal infection, LOS 
structures that cannot be sialylated may be important for 
efficient cell invasion. In the context of this report, such struc- 
tures could be achieved either by the efficient addition of the 
terminal GalNAc or by shortening the LOS chain by silencing 
the GIcNAc transferase.  The correlation of LOS chemistry 
with biological reaction has been complicated by the leaki- 
ness of the existing LOS mutants isolated by pyocin selection 
(38, 74). This is in fact exemplified with mutant 1291e, which 
shows, in addition to the major low molecular weight band, 
an additional higher band (Fig. 7). The new insight provided 
into the genetics of the biosynthesis of gonococcal LOS will 
allow construction of mutants that are not leaky. For instance, 
A4 and A5 should be stable  mutants since they no longer 
contain genes with poly-G tracts. The expression of the genes 
containing the poly-G tracts could be stabilized by engineering 
the areas so  that glycines are encoded by other codons. 
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